PREINDUCTION INTRAVENOUS LABETALOL FOR ATTENUATING INTUBATION STRESS RESPONSE DR. A. KARTHIK KILPAUK MEDICAL COLLEGE KILPAUK MEDICAL COLLEGE.

Slides:



Advertisements
Similar presentations
Nitrous Oxide and the Second Gas Effect on Emergence from Anesthesia
Advertisements

Effect of high pressure-volume and low pressure-volume mechanical ventilation on plasmatic levels of IL-6, TNF-α, neutrophil elastase (ELT) and myeloperoxidase.
Rapid Sequence Intubation Khalid Al-Ansari, FRCP(C), FAAP(PEM)
Lecturer of anesthesia & intensive care Faculty of medicine Ain Shams University 2012.
Emergency Department Patient Hypertensive Emergencies: What treatment modalities do emergency physicians utilize in the ED?
Sympathetic Drugs. Stress and The Adrenal Glands.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
CO AUTHORS PROF. DR.I.CHANDRASEKARAN MDDA PROF. DR S.P.MEENAKSHISUNDARAM MDDA ASST PROF. DR.G.VIJAYA MD AUTHOR DR.H.VIJAYALAKSHMI MD PG INSTITUTE OF ANAESTHESIOLOGY.
Module: Session: Advanced Care Paramedicine Advanced Airway Care (RSI) 5 3.
Statistical Fridays J C Horrow, MD, MS STAT Clinical Professor, Anesthesiology Drexel University College of Medicine.
The Vexing Problem of Vasoplegia
A SMOOTH EMERGENCE Lidocaine vs. Alfentanil: its uses perioperatively Jerod Schell, SRNA Oakland University-Beaumont Hospital Graduate Program of Nurse.
Alpha-Adrenergic Blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenoceptor Blockers
ADRENERGIC ANTAGONITS
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Results (cont’d) Results. Abstract Methods Methods (cont’d) Purpose Conclusions Authors: David Cooley Effects of cooling and heating fans on thermoregulation.
Pre-operative evaluation for diabetic cardiac autonomic neuropathy and their behaviour during regional anesthesia - Dr.s.sivakumar m.d anesthesiology(III.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
Anesthesia for Cesarean Section -Emergent C/S & General Anesthesia Department of Anesthesiology,NTUH R3 Chang-Fu Su.
Adrenergic antagonist sympatholytic
Jacob Hummel M.D. Tulane University Anesthesiology.
Comparison of Blood Pressure Lowering with Hydrochlorothiazide and Chlorthalidone Kurt A. Wargo, Pharm.D., BCPS, Thomas M. English, Ph.D., Anna J. Aaron,
Management of hypertensive urgencies & emergencies.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 19 Indirect-Acting Antiadrenergic Agents.
2009 Pandemic Education Package Pharmacology Review.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Adrenergic preparations
Drugs Affecting Blood Pressure Brenda B. Rowe. Vasopressors Treat shock Treat shock Dopamine (Intropin) – stimulates alpha-1 & beta-1 Dopamine (Intropin)
A NAPHYLAXIS M ANAGEMENT. 3 R S FOR T REATING A NAPHYLAXIS.
COMPARISON OF RAMOSETRON AND ONDANSETRON FOR PREVENTING POST OPERATIVE NAUSEA AND VOMITING AFTER LAPAROSCOPIC SURGERY Dr.T.VANITHA D.A POST-GRADUATE CO-AUTHORS.
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Spinal Anaesthesia Dr.M.Kannan MD DA Professor And HOD Department of Anaesthesiology Tirunelveli Medical College.
Dr. ANJU PADMALAYAN PG CO AUTHORS: Prof.& HOD Dr.I.CHANDRASEKARAN MD, DA Prof.Dr.GANESH PRABHU MD, DA., Asst.Prof.Dr. SIVAPRASATH MD., INSTITUTE OF ANAESTHESIOLOGY.
Spinal Anaesthesia.
Bispectral Index Guided Anesthetic Practice in Cardiac Surgery Dr. Mohamed Essam, MD Assistant Professor, Anesthesia Department Ain Shams University.
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Dr. V.Philitsen.. MY GUIDE PROFESSOR Dr. P.S.SHANMUGAM, M.D.,D.A H.O.D. OF ANESTHESIOLOGY KILPAUK MEDICAL COLLEGE CHENNAI.
OVERTURE FDA Cardiovascular and Renal Drugs Advisory Committee Meeting July 19, 2002 Milton Packer, M.D., FACC Columbia University College of Physicians.
ANS True or False Rationale. If I were admitted with decreased circulation to my toes which are blue and painful, you would give me an alpha blocker.
Drug action on Sympathetic Nerves: No. 3: Sympatholytic drugs
Journal Club Britni Fabacher Hebert, PGY 4. Angiotensin Blockade in the Perioperative Period  Case Presentation  Brief Review of Angiotensin Blockage.
Endotracheal Intubation – Rapid Sequence Intubation
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Dexmedetomidine Lowers the Concentration of Anesthetic Required during Craniotomies below MAC Garett J. Pangrazzi, BS, Jacob A. Uhler, BA, Prashanth R.
INTRA-VENOUS INDUCTION AGENTS Dr.M.Kannan MD DA Professor And HOD Department of Anaesthesiology Tirunelveli Medical College.
Melanie Tan C is for Circulation Locum Consultant in Anaesthesia, UCLH.
Adrenergic Antagonists
Neuromuscular Blockers
INFLUENCE OF UPPER AND LOWER LIMB EXERCISES IN REVIVING BLOOD PRESSURE IN HYPERTENSIVE PATIENTS ANUM HAIDER (BSPT, MSPT, ADPT)
Investigation of the effects of ß-blockers on CVS
EFFECT OF SYSTEMIC GRANISETRONE IN THE CLINICAL COURSE OF SPINAL ANESTHESIA WITH HYPERBARIC BUPIVACAINE FOR OUTPATIENT CYSTOSCOPY Sussan Soltani Mohammadi,M.D.
Intravenous clonidine for controlled hypotension in Functional Endoscopic Sinus Surgery under general anaesthesia Professor. Subramani Kandasamy Assoc.
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
Conscious Sedation March, 2012.
Traditional parenteral antihypertensive treatment
Dr. Mohamed AlKhayarine
β – ADRENERGIC BLOCKERS
Airway management Second cause of mortality in anaesthesia in 1996 in France = 1/3 of the anaesthesia mortality. 600 deaths in UK in to 30% of.
Dr. PJ Devereaux on behalf of POISE Investigators
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Beta blockers and anesthesia
Dr.s.sivakumar m.d anesthesiology(III year) Kilpauk medical college
Drugs Affecting Blood Pressure
Presentation transcript:

PREINDUCTION INTRAVENOUS LABETALOL FOR ATTENUATING INTUBATION STRESS RESPONSE DR. A. KARTHIK KILPAUK MEDICAL COLLEGE KILPAUK MEDICAL COLLEGE

GUIDE : GUIDE : PROF. DR. P.S.SHANMUGAM, MD, DA PROF. DR. P.S.SHANMUGAM, MD, DA HEAD OF DEPARTMENT HEAD OF DEPARTMENT DEPARTMENT OF ANAESTHESIOLOGY, DEPARTMENT OF ANAESTHESIOLOGY, KILPAUK MEDICAL COLLEGE. KILPAUK MEDICAL COLLEGE. ETHICAL COMMITTEE APPROVAL OBTAINED

AIM OF THE STUDY To study and compare the effects of Preinduction intravenous Labetalol at incremental doses of 0.25mg/kg & 0.5mg/kg in attenuation of intubation stress response in General Anaesthesia To study and compare the effects of Preinduction intravenous Labetalol at incremental doses of 0.25mg/kg & 0.5mg/kg in attenuation of intubation stress response in General Anaesthesia

STUDY DESIGN Randomized, Prospective study Randomized, Prospective study Pre study assessment done and consent obtained from all the patients Pre study assessment done and consent obtained from all the patients

PATIENT SELECTION INCLUSION CRITERIA : INCLUSION CRITERIA : 45 patients of ASA grade I & II 45 patients of ASA grade I & II Age 18 – 60 yrs Age 18 – 60 yrs Both sex Both sex Elective surgery requiring general anaesthesia with endotracheal intubation Elective surgery requiring general anaesthesia with endotracheal intubation

EXCLUSION CRITERIA : EXCLUSION CRITERIA : Patient contraindicated to  -blocker; eg- Bronchial Asthma, Peripheral vascular disease, conduction defects Patient contraindicated to  -blocker; eg- Bronchial Asthma, Peripheral vascular disease, conduction defects Hypertensive patients, patients on Anti-HT drugs Hypertensive patients, patients on Anti-HT drugs Systolic BP < 90mmHg; HR< 50/mt Systolic BP < 90mmHg; HR< 50/mt Having preoperative airway or intubation problems Having preoperative airway or intubation problems Awake intubation or intubation taking more than 20sec or requiring second attempt are excluded Awake intubation or intubation taking more than 20sec or requiring second attempt are excluded

GROUPS GROUP A : 15 patients receiving IV Normal saline (Placebo) prior to induction (Control) GROUP A : 15 patients receiving IV Normal saline (Placebo) prior to induction (Control) GROUP B : 15 patients receiving Inj. Labetalol 0.25mg/kg prior to induction GROUP B : 15 patients receiving Inj. Labetalol 0.25mg/kg prior to induction GROUP C : 15 patients receiving Inj. Labetalol 0.5 mg/kg prior to induction GROUP C : 15 patients receiving Inj. Labetalol 0.5 mg/kg prior to induction

MONITORING Pulse oximetry Pulse oximetry NIBP NIBP ECG ECG

METHODOLOGY 45 patients randomized into three groups of 15 each 45 patients randomized into three groups of 15 each Premedication: Given i.m 45 min prior to surgery Premedication: Given i.m 45 min prior to surgery  Inj. Glycopyrrolate 10ug/kg  Inj. Pentazocine 0.5mg /kg Preoxygenation : 100% O2 for 5 min Preoxygenation : 100% O2 for 5 min Inj Labetalol/ Normal saline given iv 5 min prior to induction Inj Labetalol/ Normal saline given iv 5 min prior to induction Induction : Inj.Propofol 2mg/kg iv Induction : Inj.Propofol 2mg/kg iv

NDMR – Inj Rocuronium 0.9mg/Kg iv NDMR – Inj Rocuronium 0.9mg/Kg iv Patient ventilated with 100% O 2 for 3 min Patient ventilated with 100% O 2 for 3 min Intubated with appropriate size ET tube Intubated with appropriate size ET tube Maintained with O2 : N2O – 1:2 Maintained with O2 : N2O – 1:2 Volatile inhalational agents used only 10min after intubation Volatile inhalational agents used only 10min after intubation

Pulse rate & NIBP were recorded: Pulse rate & NIBP were recorded: Preoperatively Preoperatively 45 min after premedication 45 min after premedication In the operating table before IV Labetalol/Normal saline In the operating table before IV Labetalol/Normal saline For every min after IV Labetalol/Normal saline for 5 min For every min after IV Labetalol/Normal saline for 5 min After Induction After Induction After giving NDMR After giving NDMR At laryngoscopy At laryngoscopy For every 1 min after Endotracheal intubation for 10min For every 1 min after Endotracheal intubation for 10min

Labetalol — Mechanism Competitive, selective  1 and non-selective  -blocker Competitive, selective  1 and non-selective  -blocker  >  blocking potency oral is 3:1, iv is 7:1  >  blocking potency oral is 3:1, iv is 7:1 It has intrinisic partial B2 agonistic activity hence causes vasodilation It has intrinisic partial B2 agonistic activity hence causes vasodilation Onset: 5-10 min Onset: 5-10 min Duration of action: 3-6hrs Duration of action: 3-6hrs T1/2 – 5-8hrs T1/2 – 5-8hrs Competitive, selective  1 and non-selective  -blocker Competitive, selective  1 and non-selective  -blocker  >  blocking potency oral is 3:1, iv is 7:1  >  blocking potency oral is 3:1, iv is 7:1 It has intrinisic partial B2 agonistic activity hence causes vasodilation It has intrinisic partial B2 agonistic activity hence causes vasodilation Onset: 5-10 min Onset: 5-10 min Duration of action: 3-6hrs Duration of action: 3-6hrs T1/2 – 5-8hrs T1/2 – 5-8hrs

CVS Effects Decrease SVR leading to decrease in BP is by alpha -1 blockade Decrease SVR leading to decrease in BP is by alpha -1 blockade Vasodilation also produced by partial B2 agonist activity Vasodilation also produced by partial B2 agonist activity Reflex tachycardia due to peripheral vasodilation is attenuated by B blockade Reflex tachycardia due to peripheral vasodilation is attenuated by B blockade Cardiac output remains unchanged Cardiac output remains unchanged Presynaptic alpha-2 receptors are spared- hence release of Norepinephrine is intact, which inhibits further release of catecholamine (Neg feedback mech) Presynaptic alpha-2 receptors are spared- hence release of Norepinephrine is intact, which inhibits further release of catecholamine (Neg feedback mech)

Adverse effects Orthostatic hypotension Orthostatic hypotension Bronchospasm Bronchospasm Others- CCF, bradycardia, Heart block Others- CCF, bradycardia, Heart block Increased plasma aminotransferase Increased plasma aminotransferase Paresthesia – scalp tingling Paresthesia – scalp tingling Urinary retention Urinary retention

STATISTICAL ANALYSIS

STATISTICAL TEST USED ANOVA test ANOVA test F test F test If significance is there, then subjected to Post Hoc Test If significance is there, then subjected to Post Hoc Test

ANALYSIS OF AGE AMONG THE GROUPS P value = 0.834, which is not significant P value = 0.834, which is not significant AGE 95% Confidence Interval for Mean Group NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C

COMPARISON OF PREOP HEART RATE AMONG THE GROUPS PRE OP HR 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.911, NOT SIGNIFICANT

COMPARISON OF PREOP SYSTOLIC BP AMONG THE GROUPS PRE OP SBP 95% Confidence Interval for Mean NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C P=0.567, NOT SIGNIFICANT

COMPARISON OF PREOP DIASTOLIC BP AMONG THE GROUPS PRE OP DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C P=0.420, NOT SIGNIFICANT

COMPARISON OF HR AFTER 5MIN OF LABETALOL IV 5 MINUTES STUDY HR 95% Confidence Interval for Mean NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C P=0.368, NOT SIGNIFICANT

COMPARISON OF SYSTOLIC BP AFTER 5MIN OF LABETALOL IV 5 MINUTES STUDY SBP 95% Confidence Interval for Mean NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C P=0.985, NOT SIGNIFICANT

COMPARISON OF DIASTOLIC BP AFTER 5MIN OF LABETALOL IV 5 MINUTE STUDY DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. Error Lower Bound Upper Bound A B C P=0.105, NOT SIGNIFICANT

COMPARISON OF HEART RATE AT LARYNGOSCOPY HR AT SCOPY 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.000, SIGNIFICANT By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.815)

COMPARISON OF HEART RATE AT 1 MIN AFTER INTUBATION SCOPY OF 1 MINUTE HR 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.001, SIGNIFICANT By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.851)

COMPARISON OF HEART RATE AT 3 MIN AFTER INTUBATION SCOPY OF 3 MINUTES HR 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.007, SIGNIFICANT By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.989)

COMPARISON OF HEART RATE AT 5 MIN AFTER INTUBATION SCOPY OF 5 MINUTES HR 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.02, SIGNIFICANT By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.827)

COMPARISON OF HEART RATE AT 10 MIN AFTER INTUBATION P=0.022, SIGNIFICANT By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.805) SCOPY OF 10 MINUTES HR 95% Confidence Interval for Mean NMeanStd. DeviationStd. ErrorLower BoundUpper Bound A B C

COMPARISON OF SYSTOLIC BP AT LARYNGOSCOPY SBP AT LARYNGOSCOPY 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.189, NOT SIGNIFICANT

COMPARISON OF SYSTOLIC BP AT 1 MIN AFTER INTUBATION SCOPY 1 MINUTES SBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.212, NOT SIGNIFICANT

COMPARISON OF SYSTOLIC BP AT 3 MIN AFTER INTUBATION SCOPY 3 MINUTES SBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.200, NOT SIGNIFICANT

COMPARISON OF SYSTOLIC BP AT 5 MIN AFTER INTUBATION SCOPY 5 MINUTES SBP 95% Confidence Interval for Mean NMeanStd. DeviationStd. ErrorLower BoundUpper Bound A B C P=0.021, SIGNIFICANT

COMPARISON OF SYSTOLIC BP AT 10 MIN AFTER INTUBATION SCOPY 10 MINUTES SBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.051, NOT SIGNIFICANT

COMPARISON OF DIASTOLIC BP AT LARYNGOSCOPY DBP AT LARYNGOSCOPY 95% Confidence Interval for Mean NMeanStd. DeviationStd. ErrorLower BoundUpper Bound A B C P=0.039, SIGNIFICANT

COMPARISON OF DIASTOLIC BP AT 1 MIN AFTER INTUBATION SCOPY 1 MINUTES DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.023, SIGNIFICANT

COMPARISON OF DIASTOLIC BP AT 3 MIN AFTER INTUBATION SCOPY 3 MINUTES DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.063, NOT SIGNIFICANT

COMPARISON OF DIASTOLIC BP AT 5 MIN AFTER INTUBATION SCOPY 5 MINUTES DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.028, SIGNIFICANT

COMPARISON OF DIASTOLIC BP AT 10 MIN AFTER INTUBATION SCOPY 10 MINUTES DBP 95% Confidence Interval for Mean NMean Std. Deviation Std. ErrorLower BoundUpper Bound A B C P=0.021, SIGNIFICANT

CONCLUSION Heart Rate: Heart Rate: Preinduction iv labetalol decreased the heart rate prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not statistically significant Preinduction iv labetalol decreased the heart rate prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not statistically significant Attenuation of heart rate at Laryngoscopy, at 1min, 3min, 5min, 7min & 10min after intubation (decrease in Group C>Group B>Group A) is statistically significant. Attenuation of heart rate at Laryngoscopy, at 1min, 3min, 5min, 7min & 10min after intubation (decrease in Group C>Group B>Group A) is statistically significant. Preop HR was achieved at 1 min after intubation Preop HR was achieved at 1 min after intubation

HEART RATE ANOVA FSig. SCOPY (0 MINUTE) HRBetween Groups SCOPY OF 1 MINUTE HRBetween Groups SCOPY OF 3 MINUTES HRBetween Groups SCOPY OF 5 MINUTES HRBetween Groups SCOPY OF 7 MINUTES HRBetween Groups SCOPY OF 10 MINUTES HRBetween Groups

CONCLUSION Systolic BP: Systolic BP: Preinduction iv labetalol had no change in the systolic BP prior to induction in the Labetalol groups at 5 min after labetalol injection. Preinduction iv labetalol had no change in the systolic BP prior to induction in the Labetalol groups at 5 min after labetalol injection. Attenuation of Systolic BP at Laryngoscopy, at 1min, 3min, 7min & 10min after intubation is not statistically significant (decrease in Group C>Group B>Group A) Attenuation of Systolic BP at Laryngoscopy, at 1min, 3min, 7min & 10min after intubation is not statistically significant (decrease in Group C>Group B>Group A) Preop systolic BP value was reached 3-5min after intubation Preop systolic BP value was reached 3-5min after intubation

SYSTOLIC BP ANOVA FSig. SCOPY 0 MINUTES SBPBetween Groups SCOPY 1 MINUTES SBPBetween Groups SCOPY 3 MINUTES SBPBetween Groups SCOPY 5 MINUTES SBPBetween Groups SCOPY 7 MINUTES SBPBetween Groups SCOPY 10 MINUTES SBPBetween Groups

CONCLUSION Diastolic BP: Diastolic BP: Preinduction iv labetalol decreased the diastolic BP prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not statistically significant Preinduction iv labetalol decreased the diastolic BP prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not statistically significant Attenuation of Diastolic BP at Laryngoscopy, at 1min, 5min, 7min & 10min after intubation is statistically significant (decrease in Group C>Group B>Group A) Attenuation of Diastolic BP at Laryngoscopy, at 1min, 5min, 7min & 10min after intubation is statistically significant (decrease in Group C>Group B>Group A) Preop diastolic BP was reached 2-3min after intubation Preop diastolic BP was reached 2-3min after intubation

DIASTOLIC BP ANOVA FSig. SCOPY 0 MINUTE DBPBetween Groups SCOPY 1 MINUTES DBPBetween Groups SCOPY 5 MINUTES DBPBetween Groups SCOPY 7 MINUTES DBPBetween Groups SCOPY 10 MINUTES DBPBetween Groups

CONCLUSION Both Group B & C showed attenuation of intubation stress response(HR, Diastolic BP & to a certain extent Systolic BP) compared to control group (Group A), but the difference between the two Labetalol groups is very less & not statistically significant. Hence Labetalol 0.25mg/kg is quiet effective & economical in attenuating stress response. Both Group B & C showed attenuation of intubation stress response(HR, Diastolic BP & to a certain extent Systolic BP) compared to control group (Group A), but the difference between the two Labetalol groups is very less & not statistically significant. Hence Labetalol 0.25mg/kg is quiet effective & economical in attenuating stress response.